| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 |
| Total Revenue | 266 | 533 | 564 |
| Cost of Revenue |
-
|
-
|
-
|
|
| Gross Profit | 266 | 533 | 564 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 456 | 795 | 775 |
| Non Recurring |
-
| 38 |
-
|
| Others |
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (190) | (300) | (211) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (190) | (300) | (211) |
| Interest Expense |
-
|
-
|
-
|
| Income Before Tax | (190) | (300) | (211) |
| Income Tax Expense | 1 | 1 | 1 |
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (191) | (301) | (212) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (191) | (301) | (212) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($191) | ($301) | ($212) |
0.51% Nasdaq 
Income Statement
